BackRepliCel Life Sciences Overview

RepliCel Life Sciences Current Assets

Track RepliCel Life Sciences's current assets ($64K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$64374.00
↓ 81.71% YoYΔ $-287622.00 vs prior year quarter

Peer trimmed avg / median

Loading

RepliCel Life Sciences Current Assets History

Loading

RepliCel Life Sciences vs. peers: Current Assets Comparison

Loading

RepliCel Life Sciences Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

RepliCel Life Sciences (RP.V) FAQ

RepliCel Life Sciences posts a current assets of $64K as of June 2024. That compares with $350K in the prior-year period — down 81.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, RepliCel Life Sciences's current assets was $350K. The latest reading is $64K — a 81.7% year-over-year decrease (period ending June 2024). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of RepliCel Life Sciences's financial statement story. At $64K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for RP.V's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; RepliCel Life Sciences's other metric pages and overview cover the third.

Judging RepliCel Life Sciences against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in current assets easier to interpret. Start with $64K here, then scan peer and history charts to see if the gap is persistent.